Rotavirus strategies to evade host antiviral innate immunity

Immunology Letters

Volumn 127, Issue 1, 2009, Pages 13-18

  Liu, Kaijun ^a   Yang, Xia ^a   Wu, Yuzhang ^a   Li, Jintao ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Innate immunity; IRF; NSP1; Rotavirus

Indexed keywords

LIVE VACCINE;

DEVELOPING COUNTRY; GASTROENTERITIS; HUMAN; INNATE IMMUNITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS SURVIVAL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; INTERFERONS; NF-KAPPA B; ROTAVIRUS; ROTAVIRUS INFECTIONS; STAT1 TRANSCRIPTION FACTOR;

EID: 70350704672     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.08.007     Document Type: Review

References (80)

1. Barro M., and Patton J.T. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci USA 102 (2005) 4114-4119
2. Wen K., Azevedo M.S., Gonzalez A., Zhang W., Saif L.J., Li G., et al. Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs. Vet Immunol Immunopathol 127 (2009) 304-315
3. Bowie A.G., and Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8 (2008) 911-922
4. Bonjardim C.A., Ferreira P.C., and Kroon E.G. Interferons: signaling, antiviral and viral evasion. Immunol Lett 122 (2009) 1-11
5. Vancott J.L., McNeal M.M., Choi A.H., and Ward R.L. The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res 23 (2003) 163-170
6. Koyama S., Ishii K.J., Coban C., and Akira S. Innate immune response to viral infection. Cytokine 43 (2008) 336-341
7. Aich P., Wilson H.L., Kaushik R.S., Potter A.A., Babiuk L.A., and Griebel P. Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus. J Gen Virol 88 (2007) 2749-2761
8. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat Immunol 7 (2006) 131-137
9. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
10. Honda K., and Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 (2006) 644-658
11. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
12. Hiscott J., Grandvaux N., Sharma S., Tenoever B.R., Servant M.J., and Lin R. Convergence of the NF-κB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann NY Acad Sci 1010 (2003) 237-248
13. Saito T., Owen D.M., Jiang F., Marcotrigiano J., and Gale Jr. M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454 (2008) 523-527
14. Takeuchi O., and Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20 (2008) 17-22
15. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
16. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 105 (2008) 5477-5482
17. Han K.J., Su X., Xu L.G., Bin L.H., Zhang J., and Shu H.B. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways. J Biol Chem 279 (2004) 15652-15661
18. Sadler A.J., and Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 8 (2008) 559-568
19. Desselberger U., Manktelow E., Li W., Cheung W., Iturriza-Gomara M., and Gray J. Rotaviruses and rotavirus vaccines. Br Med Bull 90 (2009) 37-51
20. Arias C.F., Isa P., Guerrero C.A., Mendez E., Zarate S., Lopez T., et al. Molecular biology of rotavirus cell entry. Arch Med Res 33 (2002) 356-361
21. Estes M.K. Advances in molecular biology: impact on rotavirus vaccine development. J Infect Dis 174 Suppl 1 (1996) S37-S46
22. Estes M.K., Conner M.E., Gilger M.A., and Graham D.Y. Molecular biology and immunology of rotavirus infections. Immunol Invest 18 (1989) 571-581
23. Hyser J.M., and Estes M.K. Rotavirus vaccines and pathogenesis: 2008. Curr Opin Gastroenterol 25 (2009) 36-43
24. Ward R.L., and Bernstein D.I. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis 48 (2009) 222-228
25. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 11-22
26. Offit P.A., and Clark H.F. RotaTeq: a pentavalent bovine-human reassortant rotavirus vaccine. Pediatr Ann 35 (2006) 29-34
27. Matson D.O. The pentavalent rotavirus vaccine, RotaTeq. Semin Pediatr Infect Dis 17 (2006) 195-199
28. Keating G.M. Rotavirus vaccine RIX4414 (Rotarix). Paediatr Drugs 8 (2006) 389-395 [discussion 396-87]
29. Bernstein D.I., and Ward R.L. Rotarix: development of a live attenuated monovalent human rotavirus vaccine. Pediatr Ann 35 (2006) 38-43
30. Bernstein D.I. Live attenuated human rotavirus vaccine, Rotarix. Semin Pediatr Infect Dis 17 (2006) 188-194
31. Li J.T., Fei L., Mou Z.R., Wei J., Tang Y., He H.Y., et al. Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 356 (2006) 171-178
32. Pesavento J.B., Crawford S.E., Estes M.K., and Prasad B.V. Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol 309 (2006) 189-219
33. Patton J.T., Silvestri L.S., Tortorici M.A., Vasquez-Del Carpio R., and Taraporewala Z.F. Rotavirus genome replication and morphogenesis: role of the viroplasm. Curr Top Microbiol Immunol 309 (2006) 169-187
34. Prasad B.V., and Chiu W. Structure of rotavirus. Curr Top Microbiol Immunol 185 (1994) 9-29
35. Shaw A.L., Rothnagel R., Zeng C.Q., Lawton J.A., Ramig R.F., Estes M.K., et al. Rotavirus structure: interactions between the structural proteins. Arch Virol Suppl 12 (1996) 21-27
36. Estes M.K., and Cohen J. Rotavirus gene structure and function. Microbiol Rev 53 (1989) 410-449
37. Ciarlet M., Conner M.E., Finegold M.J., and Estes M.K. Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol 76 (2002) 41-57
38. Cordle C.T., Schaller J.P., Winship T.R., Candler E.L., Hilty M.D., Smith K.L., et al. Passive immune protection from diarrhea caused by rotavirus or E. coli: an animal model to demonstrate and quantitate efficacy. Adv Exp Med Biol 310 (1991) 317-327
39. Schaller J.P., Saif L.J., Cordle C.T., Candler Jr. E., Winship T.R., and Smith K.L. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J Infect Dis 165 (1992) 623-630
40. Wolf J.L., Cukor G., Blacklow N.R., Dambrauskas R., and Trier J.S. Susceptibility of mice to rotavirus infection: effects of age and administration of corticosteroids. Infect Immun 33 (1981) 565-574
41. Ramig R.F. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 78 (2004) 10213-10220
42. Lundgren O., and Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 3 (2001) 1145-1156
43. Estes M.K., Kang G., Zeng C.Q., Crawford S.E., and Ciarlet M. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp 238 (2001) 82-96 [discussion 96-100]
44. Patton J.T., Vasquez-Del Carpio R., and Spencer E. Replication and transcription of the rotavirus genome. Curr Pharm Des 10 (2004) 3769-3777
45. Lu X., McDonald S.M., Tortorici M.A., Tao Y.J., Vasquez-Del Carpio R., Nibert M.L., et al. Mechanism for coordinated RNA packaging and genome replication by rotavirus polymerase VP1. Structure 16 (2008) 1678-1688
46. Franco M.A., Angel J., and Greenberg H.B. Immunity and correlates of protection for rotavirus vaccines. Vaccine 24 (2006) 2718-2731
47. 2+in the replication and pathogenesis of rotavirus and other viral infections. Cell Calcium 28 (2000) 137-149
48. Angel J., Tang B., Feng N., Greenberg H.B., and Bass D. Studies of the role for NSP4 in the pathogenesis of homologous murine rotavirus diarrhea. J Infect Dis 177 (1998) 455-458
49. Ward L.A., Rosen B.I., Yuan L., and Saif L.J. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 77 Pt 7 (1996) 1431-1441
50. Riepenhoff-Talty M., Dharakul T., Kowalski E., Sterman D., and Ogra P.L. Rotavirus infection in mice: pathogenesis and immunity. Adv Exp Med Biol 216B (1987) 1015-1023
51. Johansen K., and Svensson L. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Arch Virol 142 (1997) 1491-1498
52. McNeal M.M., Stone S.C., Basu M., Bean J.A., Clements J.D., Hendrickson B.A., et al. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology 346 (2006) 338-347
53. Feng N., Lawton J.A., Gilbert J., Kuklin N., Vo P., Prasad B.V., et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest 109 (2002) 1203-1213
54. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., and Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272 (1996) 104-107
55. Bass D.M. Interferon γ and interleukin 1, but not interferon α, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113 (1997) 81-89
56. Holloway G., Truong T.T., and Coulson B.S. Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2 and NF-κB. J Virol 83 (2009) 4942-4951
57. Feng N., Kim B., Fenaux M., Nguyen H., Vo P., Omary M.B., et al. Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol 82 (2008) 7578-7590
58. Douagi I., McInerney G.M., Hidmark A.S., Miriallis V., Johansen K., Svensson L., et al. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. J Virol 81 (2007) 2758-2768
59. Mesa M.C., Rodriguez L.S., Franco M.A., and Angel J. Interaction of rotavirus with human peripheral blood mononuclear cells: plasmacytoid dendritic cells play a role in stimulating memory rotavirus specific T cells in vitro. Virology 366 (2007) 174-184
60. Angel J., Franco M.A., Greenberg H.B., and Bass D. Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J Interferon Cytokine Res 19 (1999) 655-659
61. Azim T., Ahmad S.M., Sefat E.K., Sarker M.S., Unicomb L.E., De S., et al. Immune response of children who develop persistent diarrhea following rotavirus infection. Clin Diagn Lab Immunol 6 (1999) 690-695
62. Jiang B., Snipes-Magaldi L., Dennehy P., Keyserling H., Holman R.C., Bresee J., et al. Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol 10 (2003) 995-1001
63. Tsuchida T., Kawai T., and Akira S. Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins. Cell Res 19 (2009) 3-4
64. Graff J.W., Mitzel D.N., Weisend C.M., Flenniken M.L., and Hardy M.E. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J Virol 76 (2002) 9545-9550
65. Kearney K., Chen D., Taraporewala Z.F., Vende P., Hoshino Y., Tortorici M.A., et al. Cell-line-induced mutation of the rotavirus genome alters expression of an IRF3-interacting protein. EMBO J 23 (2004) 4072-4081
66. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., et al. Translational control of the innate immune response through IRF-7. Nature 452 (2008) 323-328
67. Yanai H., Chen H.M., Inuzuka T., Kondo S., Mak T.W., Takaoka A., et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA 104 (2007) 3402-3407
68. Graff J.W., Ewen J., Ettayebi K., and Hardy M.E. Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J Gen Virol 88 (2007) 613-620
69. Barro M., and Patton J.T. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81 (2007) 4473-4481
70. Feng N., Sen A., Nguyen H., Vo P., Hoshino Y., Deal E.M., et al. Variation in rotavirus NSP1 antagonism of the IFN response results in differential infectivity in mouse embryonic fibroblasts. J Virol 83 (2009) 6987-6994
71. Chaibi C., Cotte-Laffitte J., Sandre C., Esclatine A., Servin A.L., Quero A.M., et al. Rotavirus induces apoptosis in fully differentiated human intestinal Caco-2 cells. Virology 332 (2005) 480-490
72. Boshuizen J.A., Reimerink J.H., Korteland-van Male A.M., van Ham V.J., Koopmans M.P., Buller H.A., et al. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol 77 (2003) 13005-13016
73. Azevedo M.S., Yuan L., Pouly S., Gonzales A.M., Jeong K.I., Nguyen T.V., et al. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J Virol 80 (2006) 372-382
74. Casola A., Estes M.K., Crawford S.E., Ogra P.L., Ernst P.B., Garofalo R.P., et al. Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology 114 (1998) 947-955
75. Graff J.W., Ettayebi K., and Hardy M.E. Rotavirus NSP1 inhibits NFκB activation by inducing proteasome-dependent degradation of β-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog 5 (2009) e1000280
76. Haye K., Bourmakina S., Moran T., Garcia-Sastre A., and Fernandez-Sesma A. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J Virol 83 (2009) 6849-6862
77. Hartman A.L., Ling L., Nichol S.T., and Hibberd M.L. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol 82 (2008) 5348-5358
78. Basu D., Walkiewicz M.P., Frieman M., Baric R.S., Auble D.T., and Engel D.A. Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol 83 (2009) 1881-1891
79. Karayiannis P. The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response. J Hepatol 43 (2005) 743-745
80. Jiang X., Jayaram H., Kumar M., Ludtke S.J., Estes M.K., and Prasad B.V. Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol 80 (2006) 10829-10835